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1. Introduction 
Kidney transplantation improves the quality of life and the long-term survival of end-stage 
renal failure (ESRF) patients compared to those on dialysis (1). It has also been shown to be 
a more economic option than both haemodialysis and peritoneal dialysis (2) 
With the increasing incidence of organ failure, the demand for organ transplantation has 
increased, resulting in longer waiting lists and increased waiting list deaths.  
Recently, live organ donation has helped to relieve the shortage of deceased donor grafting. 
Living donor kidney transplantation offers recipients the best hope for long-term 
rehabilitation and its advantages are indisputable.  
This chapter looks at the anaesthetic principles and management of kidney transplantation, 
the most frequently performed organ transplantation.  
2. Preoperative assessment  
Hypertension and diabetes mellitus (DM) are the two most common causes of ESRF 
Hypertension should be assessed thoroughly in terms of severity, antihypertensive 
medications and cardiovascular complications. Hypertension associated with renal failure is 
usually treated with ACE inhibitors or angiotensin II receptors antagonists. (3) 
A target blood pressure of 140/90 or less is usually associated with decreased incidence of 
left ventricular hypertrophy. (4) 
Type 1 DM is usually associated with impaired renal function and can lead to the 
development of severe nephropathy and ESRF. Diabetic patients have increased 
cardiovascular risk of peripheral vascular disease. (5) 
There are few other medical problems associated with advanced kidney diseases, such as: 
- Endocrine abnormalities such as hyperparathyroidism  
- increased calcium and phosphate serum levels. 
- Dyslipidaemia 
- Autoimmune diseases as vasculitis – Systemic Lupus Erythematosus (SLE) 
3. Medical history  
The preoperative visit plays an important role to alleviate patient’s anxiety, especially for 
patients who have been suffering from a life-long kidney problem and anticipating to 
undergo a procedure that would change their life style completely. 
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The importance of such a visit to the anaesthetist cannot be over-emphasised, many of these 
patients have had general anaesthesia in the past, so useful information may be found from 
previous anaesthesia charts. 
The aetiology of a failing kidney cannot be clearly identified every time, but it is important 
to be aware of the cause if this has been identified, as this may have other implications to the 
anaesthetic management. The associated morbidity, whether it is the cause of the renal 
failure or as a consequence of it, has to be sought very clearly. 
The duration of renal failure and the requirement of any renal replacement therapy (RRT), 
either peritoneal dialysis (PD) or haemodialysis (HD) must also be noted. The longer the 
duration of renal failure, the more likely there will be implications to the anaesthetic 
management, for example the patient may have required numerous central venous 
cannulations in the past, resulting in stenosed or thrombosed central veins or they have had 
numerous arterio-venous (AV) fistulas which make intravenous access difficult.  
It is useful to be aware of the patient’s ‘dry weight’ as this will allow estimation of the 
preoperative fluid status. The frequency of dialysis per week should be asked and the last 
dialysis session the patient received must also be noted. Ideally this should be as close to 
surgery as possible. This will ensure optimised fluid balance (although the patient may be 
under filled after a session) and electrolyte balance, most importantly the potassium and 
urea levels. A higher potassium plasma concentration can be accepted in this group of 
patients, but always try to achieve a normal range.  
If the patient is due a dialysis session or has elevated electrolyte levels and appears fluid 
overloaded, then this patient must undergo haemodialysis prior to general anaesthesia and 
surgery.   
The normal daily fluid intake and daily volume of any native urine output (if present) 
should also be noted, this will act as a further guided to fluid management intra-operatively.  
Prior to anaesthesia, the presence of any AV fistulas should be clearly marked and labelled 
to avoid cannulation and BP measurements.  
A history of previous dialysis line or central line insertions into the internal jugular or 
subclavian veins should also be sought; this may have implications on the insertion of 
central lines for monitoring during the kidney transplantation. Long term dialysis lines or 
numerous central lines can cause stenosis and thrombosis of the central veins.   
Exercise tolerance can give an indication of the severity of the condition and its associated 
problems, it is also a useful guide to the general health of the patient. 
4. Examination 
Routine examination includes vital signs and the state of hydration. Is the patient dry after 
recent dialysis or fluid overloaded? 
Some patients presenting for renal transplant might have associated rare medical conditions 
that require thorough examination, conditions like Prune Belly syndrome  and VATER 
association (please see later). 
Particular attention should be made to the cardiovascular system, including blood pressure 
control and clinical signs of left ventricular hypertrophy (LVH).   
Assessment of the respiratory system will determine further management of the patients 
following their surgery, if they have associated respiratory disease then they may require 
post-operative non-invasive ventilation or prolonged intubation and ventilation.   
Airway assessment will determine the management of the patient’s airway following 
induction of anaesthesia, but these patients should always be intubated and ventilated for a 
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renal transplant. Patients with DM may have associated difficult airways so appropriate 
equipment and techniques for managing the difficult airway must be available.  
5. Investigations 
Routine investigations such as full blood count (FBC) and kidney function particularly 
serum creatinine and blood urea nitrogen (BUN) and creatinine clearance. 
Serum potassium should to be within the normal levels; usually less than 5.5 mmol/L. A 
further cycle on dialysis may be required if raised. Also note the bicarbonate and base 
excess.  
Lots of important information can be obtained from the electrocardiogram (ECG), such as  
left ventricular hypertrophy, ischaemic heart disease or ECG changes associated with 
electrolyte imbalances, especially hyperkalaemia.  
If the patient has a significant history of cardiovascular disease with associated ECG 
changes, then further assessment maybe required, such as an echocardiogram, radioactive 
isotope scan or even angiography. Patients with ESRF as a result of DM, may have 
undiagnosed cardiovascular disease, so particular care should be taken in these patients.  
All patients undergoing renal transplant should at least have blood group and saved, blood 
should be made available if there is a high risk of bleeding.  
6. Anaesthetic technique 
Normally patients are not prescribed pre-medications prior to induction of anaesthesia, 
unless strongly indicated. Temazepam can be given orally 10 – 20 mg the night before 
and/or the morning of surgery in particularly anxious patients. Rantidine, metoclopramide 
or sodium citrate orally may also be given if the patient has reflux disease.  
Induction of anaesthesia always takes place with the routine monitors ECG, non-invasive 
blood pressure and oxygen saturation monitoring. In patients with associated 
cardiovascular disease, invasive blood pressure monitoring should be considered, to ensure 
close monitoring of the blood pressure.  
Haemodynamic stability should be maintained throughout the period of the operation with 
special attention to depressing the vasopressor response to intubation. 
Fluctuations of the blood pressure should be within 20% of the baseline reading, this can be 
achieved by dampening surgical stimulation with the use of opioids.  
Intraoperative opioids can be achieved via repeated boluses of Fentanyl or continuous 
infusion of Remifentanil, as target controlled infusion (TCI) between 4 to 6 ng/mL.   
Atracurium (0.5 mg/Kg) is the muscle relaxant of choice in renal failure, it undergoes 
Hofmann degradation mainly and ester hydrolysis to a lesser extent. 
Other muscle relaxants can be used, including all non-depolarizing muscle relaxants, but 
care must be taken with large or repeated doses as accumulation may result in a prolonged 
neuromuscular block.  
The only depolarizing muscle relaxant in clinical use (suxamethonium) can be used as long 
as serum potassium levels are less than 5 mmol/L. 
After induction of anaesthesia a central line should be inserted, ideally with ultrasound 
guidance, this allows monitoring of central venous pressure and the infusion of inotropes if 
necessary. The preferred site of insertion should be the internal jugular vein, be careful with 
the subclavian approach, particularly if on the fistula side as the vein may be arterialised 
and bleed profusely.  
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Immediately following induction of anaesthesia prophylactic dose of antibiotic should be 
given, this can vary depending on local protocol, commonly used are: 
Amikacin 5 mg/Kg or gentamicin 3 mg/Kg  
Co-amoxiclav dose 1.2 g can be given as well 
Transplant surgery requires the administration of ‘goodies’, to reduce the incidence of organ 
rejection and to help functioning of the transplanted kidney. These are usually administered 
prior to revascularization and vary from centre to centre. Commonly used drugs are 
furosemide, mannitol, methylprednisolone (which should given as a slow intravenous 
infusion over half an hour, if given as a bolus it causes marked vasodilatation and may 
cause pronounced hypotension).  
7. Maintenance of anaesthesia  
All inhalational agents can be used safely, with the exception of enflurane (which is hardly 
being used in clinical practice nowadays) 
Total intravenous anaesthesia (TIVA) is successfully being used with propofol and 
remifentanil to maintain GA.  
The use of nitrous oxide is not associated with any ill effects, having said that, there is a 
trend among anaesthetists to avoid the use of N2O in patients even with a normal kidney 
function. 
The combination of Desflurane and Remifentanil infusion ensures smooth anaesthesia and a 
quick response to the challenging heart rate and blood pressure control throughout the 
procedure. This is in addition to smooth and rapid recovery. 
Fentanyl can be given cautiously towards the end of the procedure in multiple small doses 
of 50 – 100 mcg; the total dose is titrated according to patient’s response to pain while 
recovering from general anaesthesia. 
8. Intraoperative monitors 
Core Temp should ideally be measured via a nasopharyngeal probe, attention should be 
paid to keep the patient’s temperature within the normal range. Hypothermia delays drug 
metabolism and is associated with increased incidence of postoperative complications 
namely chest infection and bleeding diathesis    
Central venous pressure (CVP) alone can be a misleading guide to fluid requirements 
throughout the operation. 
Oesophageal Doppler can be used to guide fluid management intraoperatively 
Arterial blood gas testing  (pH , PaO2 , PaCO2, bicarbonate, lactate, haemoglobin, potassium, 
sodium and blood glucose) is helpful if an arterial line has been placed, alternatively a 
venous sample could be used.  
Serum potassium can go either way. Hypokalaemia should not be treated unless K is less 
than 3.0 mmol/L. Where as hyperkalaemia should be dealt with if K levels is 6.0 mmol/L or 
more.  Calcium gluconate is the drug of choice in this case, as opposed to the traditional 
dextrose-insulin regimen. 
Neuromuscular blockade monitor, an additional dose of muscle relaxants has to be judged 
carefully. Adequate reversal of the neuro-muscular function is extremely important before 
planning extubation at the end of the procedure. 
Bi-spectral index (BIS) monitor can be used to assess depth of anaesthesia. 
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9. Fluid management 
Transplant procedures are routinely short duration, minimal blood loss and preserved 
capillary permeability. 
Patients undergoing renal transplant operations are usually receiving haemodialysis and 
their intravascular filling status should be monitored closely. The risk of hypovolaemia and 
under-filling can impair the perfusion to the transplanted kidney, whereas hypervolaemia 
from overzealous infusion of intravenous fluids can adversely affect myocardial 
contractility, especially for patients with pre-existing coronary artery disease (CAD) and 
impaired left ventricular function. 
Even fluid balance and maintenance of the eu-volaemic status is strongly advisable 
Type of intravenous fluid is of great importance, as the use of 0.9% sodium chloride is 
thought to be the standard fluid to be used in transplants patients, but the use of other 
crystalloid fluids such as Hartmann’s solution (Lactated Ringer’s) was used safely as long as 
serum potassium levels are monitored closely. (6) 
Colloids could also be used safely in these procedures as long as its use does not exceed 15 
mL/Kg. 
Careful monitoring of the filling status of the patient is paramount, the use of central venous 
pressure (CVP) as the sole indicator or in combination with other monitors such as 
oesophageal doppler is advised. (7) 
Immediate urine output can be seen in 90% of live kidney donation and up to 50% of 
cadaveric donation. Appropriate fluid management is the single most important factor to 
determine good urine output following the transplant. 
It has been clearly demonstrated that it is more important than other pharmacological 
agents such as dopamine or the use of mannitol and colloids  
Blood transfusion is better avoided in transplant procedures as the activation of 
autoimmune system may induce early rejection of the graft. 
Renal failure patients are always anaemic, and it is quite safe to keep their haemoglobin 
levels as low as 7.0 g/dL in the perioperative period as long as continuous haemoglobin 
monitoring is available. It is a compromise between a low haemocrit that helps flow to the 
new kidney and the oxygen carrying capacity and delivery of oxygen to the tissues  
10. Low Dose Dopamine (LDD) 
Dopamine exerts its effect - at this low dose – mainly via peripheral dopaminergic receptors 
(renal) rather than its effect via the adrenergic receptors (cardiovascular) (8) 
Few studies have shown that dopamine infusion at a rate of up to 2.5 mcg/Kg/min. would 
increase both urine output and creatinine clearance (9) 
Other studies have questioned the value of dopamine infusion following graft of denervated 
kidney as evidenced by Doppler examination of renal blood flow (10), (11). The rational 
behind the use of dopamine – in the first 12 hr postoperatively - is mainly to ensure 
arteriolar vasodilatation and increase the renal perfusion pressure and to prevent acute 
tubular necrosis (ATN). There is no clear benefit from infusing or withholding dopamine, it 
is usually left to individual institution guidelines and protocols.  
If the patient’s blood pressure is thought to be high enough to grant satisfactory renal blood 
flow and ensure adequate reperfusion of the graft, then here is no need to initiate a 
dopamine infusion. 
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It is important to maintain adequate mean arterial pressure and central venous pressure 
prior to the release of the clamps once the donor kidney has been transplanted. This will 
ensure good blood flow to the kidney. The target values are dependant on the patient’s 
normal mean arterial pressures.  
11. Postoperative management 
The postoperative fluid management is an important part of maintaining adequate renal 
perfusion. Various regimes are available. One commonly used is, crystalloid 50mls/hr plus 
previous hour’s urine output. The urine output should be closely monitored and liase 
closely with the surgeons, especially if the patient remains anuric.  
Local anaesthesia wound infiltration with L-Bupivacaine (2 mg/Kg) by the surgeons at the 
end of surgery, may help reduce post-operative pain.  
Fentanyl patient controlled analgesia (PCA) is the standard pain control method 
Bolus dose 10 to 20 mcg with 5 minutes lock out interval and no background infusion, but if 
high doses of opiates are anticipated or required a background infusions can be established, 
with careful monitoring.  
Morphine can be used for postoperative pain control following transplant procedures; care 
must be exercised as accumulation of its metabolite morphine-6 glucuronide (M-6-G) may 
occur (12) 
12. Regional anaesthesia 
The use of epidural for renal transplant surgery is rare and controversial; the main reason is 
that uraemic patients tend to have a tendency to develop coagulopathy. 
Few recent studies have shown that it is a safe technique to use as long as prothrombin time 
(PT) is normal and the patient should have heparin-free dialysis sessions before epidural 
placement. 
Epidural can be used as the sole anaesthetic technique or in combination with GA. 
Both techniques were found to have similar encouraging results with respect to early graft 
function. The level of insertion is usually low thoracic to high lumbar (T12 – L1 or L1 – L2). 
Local anaesthetic infusion of Levo-Bupivacaine or Ropivacaine can be used safely. (13) 
Facilities to continuously monitor the neurological status of the patient, and to pick early 
signs of epidural haematoma should be readily available. (14) 
13. DVT Prophylaxis 
Intraoperatively TEDS elastic stockings and flowtron boots should be routinely used. Un-
fractionated Heparin 5000 iu twice daily subcutaneously should be prescribed post-
operatively. LMWH are to be avoided, as their metabolic end products are execreted via the 
kidney and can adversely affect the renal function 
14. Conclusion  
Kidney transplantation is the only definitive modality of treating ESRF  
Patients undergoing transplant procedures present many challenges to the anaesthetist. 
Success of transplant is all-dependent on thorough preoperative, close intraoperative 
monitoring and appropriate fluid management.  
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The anaesthetic technique plays an important role to ensure the immediate success of the 
graft. (15) 
15. Prune Belly syndrome 
This is a congenital abnormality mostly occurring in boys, with an incidence of 1 in 30,000 
live births, it is of unknown aetiology and has three characteristic features: 
underdevelopment of the abdominal muscles, undescended testis and abnormalities of the 
urinary tract (most commonly hydronephrosis and vesico-ureteric reflux). Mortality is as 
much as 50% before the age of 2 years, depending on the type and severity of the 
abnormalities. 25-30% of patients develop chronic renal failure, often requiring renal 
transplantation. This group of patients has several features which could pose problems for 
the anaesthetist, so anaesthetic management must focus on airway, pulmonary and renal 
systems. Micrognathia, pulmonary hypoplasia and urinary tract abnormailities should all be 
evasluated prior to anaesthesia.  
16. VATER association 
This arises from abnormalities in mesodermal differentiation and is an acronym for 
Vertebral abnormality, Anal atresia, Trachoe-oesophageal fistula with oEsophageal atresia 
and Renal dysplasia. Renal failure is a common, there is also an increased frequency of 
mental retardation and these patients may also have cardiac anomalies such as ASD, VSD 
and dextrocardia. Anaesthesia for this group of patients must focus on the cardiovascular, 
respiratory and renal systems.  
17. Anaesthesia for Hand-assisted Laparoscopic Donor Nephrectomy 
Hand-Assisted laparoscopic donor nephrectomy (HALDN) is a fairly novel technique to 
harvest the kidney from a live donor. 
It is minimally invasive technique compared to the standard open surgical approach. 
The donor is a healthy individual, who is usually related to the recipient. He/she can be 
either ASA grade 1 or 2 (i.e. with a mild systemic illness that does not affect his 
physiological reserves). 
The conduct of anaesthesia in such cases is not different from any other laparoscopic 
procedure. 
The airway should be secured with a re-enforced endotracheal tube. 
Position of the patient is the lateral decubitus, with the operating table broken in the middle 
The patient should be securely strapped to the table firmly in order to prevent any change to 
his position during the operation. 
Careful positioning needs extra-padding to protect nerves and bony prominences, the upper 
arm has to be kept in neutral position on an arm support. 
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